In one fell swoop, reverses to normal all risk factors
New Delhi : It is a wow moment for spice cinnamon ( Daal Chini). From a run of the mill household spice, it has assumed the aura of a great neutraceutical, thanks to a robust research led by renowned diabetologist Dr. Anoop Mishra. In one fell swoop, it has been found to reverse all the risk factors for diabetes and heart disease.
At least it is great news for Delhites who are at the cusp of a diabetes epidemic. About 20 percent of Delhites are already diabetic. So, those who want to avert the mother of all diseases should start dusting their eatables with cinnamon powder. Based on this research, a time may also come when tablets of cinnamon would be available in the market because tablets were used in the research.
It is this first of its kind research in the world to scientifically asses the medicinal properties embodied by cinnamon. All 58 persons on whom effect of cinnamon was tested had abdominal obesity, high triglycerides, low HDL, high blood sugar and high blood pressure. But, in 4 months of the research, all their metabolic abnormalities reverted to the normal.
In a randomized double-blind control clinical trial, the National Diabetes, Obesity &Cholesterol Foundation (N-DOC), Institute of Home Economics (University of Delhi)and Fortis CDOC Hospital for Diabetes and Allied Sciences investigated the effect of simple dietary intervention i.e. cinnamon among Indians, who have much greater propensity to develop multiple metabolic problems leading to diabetes at an early age.
Recognizing the important implications of this research, the study has been published by the leading international medical journal, Lipids in Health and Disease, in its June 2017 issue). Lipids in Health and Disease, published from USA (Biomed Central) are the world’s leading peer reviewed journal.
Dr. Anoop Misra, Director, National Diabetes Obesity and Cholesterol Foundation and Chairman, Fortis CDOC Hospital for diabetes said, ‘Purported beneficial properties of traditional Indian herbs and spices need to be proven on anvil of hard scientific methods. Looking at the results of our robust scientific study, now I can say with confidence that Cinnamon should be included in meals by all adult Indians, and particularly those who have multiple metabolic risk factors or diabetes.”
Dr. Seema Puri, Associate Professor at Institute of Home Economics, University of Delhi said, ‘The promising results of this research reveal that simple functional foods can have tremendous health benefits. Cinnamon is a spice which is commonly used in Indian cookin.It can be easily incorporated in our daily dietaries, which will balance out metabolism better.’
Dr. Sonal Gupta Jain, Assistant Professor at Institute of Home Economics, University of Delhi says, “This research proves that usage of simple dietary intervention such as judicious and recommended usage of cinnamon can lead to multiple health benefits. Cinnamon has therefore proven to be a cost effective measure for the prevention and management of multiple metabolic risk factors among Indians, who are markedly prone to develop these problems.”
Results of the research:
The results of the trial demonstrated multiple health benefits. Participants consuming cinnamon capsules showed the following results in comparison to the control group:
- Weight: Decreased 3.8%(from 89.1 kg to 85.6 kg)
- Body Mass Index and Body Fat: Reduction of 3.9% (from 33.6 kg/m2 to 32.3 kg/m2) in BMI and 4.3% (from 37.9 to 36.4) of body fat percentage.
- Waist Circumference: Decrease in 5.3% (from 106.6 cm to 101 cm).
- Blood Pressure: Significant improvement in systolic by 9.7%(from 135.8 mmHg to 122.2 mg/Hg) and diastolic blood pressure (DBP) by (from 9.1% 88.0 mmHg to 79.9 mg/Hg).
- Blood Glucose Variables:
- Fasting blood glucose decreased by 7.1% (from 102.7 mg/dl to 95 mg/dl);
- Post prandial glucose decreased by 6.8% (from 134.6 mg/dl to 124.9 mg/dl)
- Glycosylated Hemoglobin (HbA1c) decreased by 5.9% (from 6.1 to 5.7).
- Significant reduction in total cholesterol by 20.9% (from 201.9 mg/dl to 181.3 mg/dl);
- Decrease in triglyceridesby16.1% (from 174.9 mg/dl to 146.7 mg/dl);
- Decrease in LDL by 12.9% (from 133.6 mg/dl to 116.2 mg/dl);
- Increase in good cholesterol; HDL by 6.2% (from 37.5 mg/dl to 39.8 mg/dl).
- Reduction of Percentage of Individuals with the Metabolic Syndrome: Prevalence of defined metabolic syndrome was significantly reduced in the intervention group (34.5%) the placebo group (5.2%).